期刊文献+

特发性肺动脉高压150例临床分析 被引量:6

Cfinical analysis of 150 patients with idiopathic pulmonary arterial hypertension
原文传递
导出
摘要 目的了解特发性肺动脉高压(IPAH)患者的人口学和临床特征。方法自2007年5月至2010年10月,在全国31个临床中心纳入经右心导管确诊的成人IPAH患者,收集所有患者的一般情况、临床特征以及血液动力学指标,并且将所有患者分为WHO肺动脉高压功能Ⅰ/Ⅱ和Ⅲ/Ⅳ级两组,比较两组患者的血液动力学特征。结果本研究共纳入150例患者。所有患者平均年龄(36±13)岁,男性50例,女性100例,男女比为1:2。体质指数为(21.3±3.5)kg/m2。乏力(123例,82.0%)和呼吸困难(112例,74。7%)是最常见的症状,肺动脉瓣第2心音亢进是最常见体征(138例,92.0%)。约有49.0%(73例)的患者WHO肺动脉高压功能分级为Ⅲ级,功能分级Ⅱ级的患者占46.0%(68例)。6min步行距离和Borg呼吸困难评分分别为(337±101)m和2.0(2.0,4.0)。93.1%(140例)患者心电图表现右心室肥厚。右心导管测右心房压为(10±6)filmHg(1mmHg=0.133kPa),肺动脉平均压(61±16)mmHg,心指数(2.3±0.8)L·min-1·m-2和肺血管阻力(1484±699)dyn·s-1·cm-5。结论IPAH多累及青壮年,以女性为主,体质指数偏低。多数患者就诊时WHO肺动脉高压功能分级较差,血液动力学状况不佳。患者血液动力学的损害与6min步行距离及心功能分级相关。 Objective To explore the demographic characteristics and clinical features of patients with idiopathic pulmonary arterial hypertension (IPAH) in China. Methods Between March 2007 and September 2010, IPAH diagnosis was confirmed by right heart catheterization in 150 adult patients from 31 clinical centers in China. Clinical and hemodynamie data were analyzed and patients were divided into WHO functional class Ⅰ/Ⅱ and WHO functional class Ⅲ/Ⅳ group. Results The mean age of 150 patients were 36 ± 13 years with female patient/male patient ratio of 2 : 1, and mean BMI was ( 21.3 ± 3.5 ) kg/m2. Fatigue (n = 123,82. 0% ) and dyspnea (n = 112,74. 7% ) are the most common symptoms. Accentuated pulmonie second sound ( P2 ) was detected in 92. 0% ( n = 138 ) of patients during physical examination, which was also the most common sign. About 49.0% ( n = 73 ) patients were WHO functional class Ⅰ/ Ⅱ patients and 46. 0% ( n = 68 ) patients were WHO functional class Ⅲ/Ⅳ patients. Six minutes walking distance (6MWD) and Borg dyspnea score was (337 ± 101 ) m and 2.0 (2. 0,4. 0) , respectively. Right ventricnlar hypertrophy was suggested by ECG in 93.1% (n = 140 )patients . Right atrial pressure was (10 ±6) mm Hg, mean pulmonary artery pressure was (61 ± 16) mm Hg, cardiac index was (2. 3 ±0. 8) L min-1 · m-2 and puhnonary vascular resistance( 1484 ±699) dyn· s-1·cm-5 in this cohort. 6 MWD (305 m ±89 m vs. 377 m ±88 m) was significantly shorter while Borg dyspnea score [3.0 (3.0,5.0) vs. 2. 0 (2.0,3, 0) I was significantly higher in WHO functional class Ⅱ/Ⅳ patients than in WHO functional class Ⅰ/Ⅱ patients. Similarly hemodynamie parameters were also worse in WHO functional class Ⅲ/Ⅳ patients than in WHO functional class Ⅰ/ Ⅱ patients ( all P 〈 0. 05 ). Conclusion Idiopathic pulmonary arterial hypertension patients in this cohort affect mostly young adults, dominated by female gender and lower body mass index. Fatigue and dyspnea are the most common symptoms and accentuated pulmonic second sound ( P2 ) is the most common sign. IPAH patients are often displaying severe functional and hemodynamie disturbance at first visit to hospitals. Dyspnea and hemodynamic impairment are related to 6MWD and WHO functional class.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2012年第8期657-661,共5页 Chinese Journal of Cardiology
基金 国家“十一五”科技支撑计划资助项目(2006BA101A07)
关键词 高血压 肺性 心室功能障碍 血液动力学 Hypertension, pulmonary Ventrieular dysfunction Hemodynamie features
  • 相关文献

参考文献21

  • 1Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation, 2010, 122 : 156-163.
  • 2Falcetti E, Hall SM, Phillips PG, et al. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 2010,182 : 1161-1170.
  • 3Sandoval J, Bauerle O, Gomez A, et al. Primary pulmonary hypertension in children: clinical characterization and survival. J Am Coll Cardiol, 1995,25:466-474.
  • 4Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension importance of cardiopulmonaty exercise testing. Circulation, 2002, 106: 319- 324.
  • 5McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coil Cardiol, 2009, 53 : 1573-1619.
  • 6Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardilogy. Eur Heart J, 2004, 25:2243- 2278.
  • 7ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002, 166:111-117.
  • 8D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 1991,115 : 343-349.
  • 9Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med, 1987,107 : 216-223.
  • 10Peacock AJ, MuFphy NF, McMurray JJ, et al. An epidemiological study of pulmonary arterial hypertension. Eur Respir J,2007,30: 104-109.

同被引文献84

  • 1林加锋,胡君佶,王毅,陈晓曙,张建华.急性重症病毒性心肌炎与急性心肌梗死的临床比较[J].心电学杂志,2006,25(1):3-6. 被引量:13
  • 2荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 3王献民,赵珊珊,刘斌,魏丽,周同甫.高原肺动脉高压190例[J].实用儿科临床杂志,2006,21(13):835-836. 被引量:3
  • 4D'AlonzoGE, BarstRJ, AyersSM, et al. Survival in patients with primary pulmonary hypertension.Results from a national prospective registry[J].Ann Intern Med,1991,115(5):343–349.
  • 5ZhangR, DaiLZ, XieWP, eta1. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era[J]. Chest,2011,140(2):301–309.
  • 6LingY, JohnsonMK, KielyDG, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension:results from the pulmonary hypertension registry of the United Kingdom and Ireland[J]. Am J Respir Crit Care Med,2012,186(8):790–796.
  • 7HumbertM, SitbonO, ChaouatA, et al. Pulmonary arterial hypertension in France:results from a national registry[J]. Am J Respir Crit Care Med,2006,173(9):1023–1030.
  • 8PeacockAJ, MurphyNF, McMurrayJJ, et al. An epidemiological study of puhnonary arterial hypertension[J]. Eur Respir J,2007,30(1):104–109.
  • 9LiuD, LiuQQ, EyriesM, et al. Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients[J]. Eur Respir J,2012,39(3):597–603.
  • 10PfarrN, Szamalek-HoeqelJ, FischerC, et al. Hemodynamic and clinical onset inpatients with hereditary pulmonary arterial hypertension and BMPR2 mutations[J].Respir Res,2011, 12 (1):99.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部